Chronic DVT ‐ antiplatelet agents plus BMP vs BMP plus placebo
Pulmonary embolism · people requiring treatment for chronic DVT
Chronic DVT ‐ antiplatelet agents plus BMP showed no clear difference in pulmonary embolism (fatal/non‐fatal) compared with BMP plus placebo (moderate certainty).
1 finding from 1 review
- Antiplatelet agents for the treatment of deep venous thrombosis 2022 · Cochrane Headline outcomes onlyRR 0.52 [0.23, 1.14]1 study · 583 participantsModerate